Overview
Whether you arrived from a “USYC vs Injective” query or from PEPS coin pages, this hub aggregates ranks, performance and module-backed signals into one canonical URL.
Quick winners
Full comparison
| Metric | USYC | INJ |
|---|---|---|
| Price | $1,867.53 | $5.00 |
| Market Cap | $3.01B | $490.41M |
| FDV | — | — |
| Volume 24h | $792.59 | $2.50M |
| Circulating Supply | — | — |
| Total Supply | — | — |
| Max Supply | — | — |
| Rank | 30.00 | 99.00 |
| Dominance | — | — |
| Liquidity | — | — |
| Volatility | +3.64% | +5.97% |
| ATH | — | — |
| ATL | — | — |
| ROI | — | — |
Performance
| Timeframe | USYC | INJ |
|---|---|---|
| 1H | — | — |
| 24H | +0.00% | +1.77% |
| 7D | — | — |
| 30D | — | — |
| 90D | — | — |
| 1Y | — | — |
| YTD | — | — |
| ALL | — | — |
Comparative chart
Technical indicators
| Indicator | USYC | INJ |
|---|---|---|
| RSI | 49.02 | 49.29 |
| MACD histogram | — | — |
| EMA20 | — | — |
| EMA50 | — | — |
| EMA100 | — | — |
| EMA200 | — | — |
| SMA50 | — | — |
| SMA200 | — | — |
| ATR | 67.35 | 0.29 |
| ADX | 21.33 | 12.19 |
| Support | 1,827.82 | 4.91 |
| Resistance | 1,960.30 | 5.07 |
| Trend | bearish | neutral |
| Momentum | 65.00 | — |
| Signal | neutral | neutral |
Automatic technical analysis
Indicator stacks for USYC/INJ currently lean on separate regimes: bearish versus neutral. Treat MACD and RSI as context, not as standalone entry triggers.
Fundamentals
| Metric | USYC | INJ |
|---|---|---|
| Consensus | — | — |
| Blockchain | — | — |
| TPS | — | — |
| Block time | — | — |
| Finality | — | — |
| Validators | — | — |
| Staking | — | — |
| TVL | — | — |
| Supply model | — | — |
| Inflation | — | — |
| Developer activity | — | 0.00 |
| Github activity | — | 118.00 |
| On-chain activity | — | — |
| Whale activity | — | — |
| Addresses | — | — |
| Gas fees | — | — |
Ecosystem
USYC
Injective
Pros and cons
Pros of USYC
- USYC typically benefits from deeper liquidity and broader market recognition inside the Top 300 set.
- Market-cap scale on USYC may dampen some idiosyncratic shocks versus smaller peers.
- Higher ranking for USYC can translate into tighter spreads on major venues.
- USYC often anchors narratives that attract sustained media and analyst coverage.
Cons of USYC
- Data gaps in niche fundamentals still apply — absence of a field is not confirmation.
- Large-cap status for USYC can mean slower percentage upside versus high-beta alternatives.
- Indicator stacks on USYC may stay stretched longer than expected in strong trends.
Pros of Injective
- Injective can offer higher relative beta when market attention rotates toward its niche.
- PEPS tracking for Injective still includes AI score and level context for monitoring.
- Diversifying versus USYC with Injective can change portfolio factor exposure.
Cons of Injective
- Incomplete fundamental coverage can hide operational or tokenomic risks.
- Relative underperformance versus USYC can persist through entire market regimes.
- Weaker market-cap standing may leave Injective more exposed to liquidity droughts.
Which looks stronger right now?
Data currently points to a probabilistic edge for USYC on size and Injective on activity. Neither reading guarantees future returns.
AI summary
This AI-assisted summary starts from live PEPS fields. USYC holds market-cap $3.01B and rank #30; Injective shows $490.41M and #99. Where liquidity and flow matter, watch Injective. Where durability matters, watch USYC. AI composite scores (57.90/46.90) compress those tensions into a single lens. In probabilistic terms, the side winning more columns may have a nearer-term edge, but tails remain fat. Revisit after the next hourly refresh.
FAQ
Which is better, USYC or Injective?
“Better” depends on horizon and risk. USYC leads on market cap today, while Injective leads the 24h move — neither is a guarantee.
Which has more upside potential, USYC or INJ?
Higher-beta assets can move more in both directions. Use performance tables and volatility, not headlines, to judge potential ranges.
Which is less risky right now?
Lower volatility and deeper liquidity usually imply milder path risk, but crypto tails remain large for both USYC and Injective.
Which has stronger developer activity?
Check the fundamentals table for developer/github fields when populated. Missing values mean the feed has no reliable reading yet.
Which looks more decentralized?
Decentralization is multi-dimensional (validators, client diversity, token distribution). This page surfaces available consensus/validator fields without over-claiming.
Which has lower fees?
Fee comparisons belong to each network’s fee market. Where gas/fee metrics exist in fundamentals, compare them; otherwise verify on explorers.
Which is better for investing?
Investing choices need personal constraints. Use this comparison as research input, then size positions with an explicit invalidation plan.
Which is better for staking?
If staking fields are present, compare yield mechanics and lockups off-platform. Staking returns are not risk-free.
Which is more used day to day?
Volume, on-chain activity and ecosystem links are practical usage proxies. Injective currently leads traded volume on this snapshot.
Which has the better recent performance?
See the performance table across 1h through 1y. The 24h leader is Injective, but longer windows can disagree.